• Oracle Offers New Set Of Microservices With Clinical One Platform

    Clinical Informatics News | After years of development, Oracle Health Sciences has released the Clinical One platform, which offers tools for security, identity management, performance, disaster recovery, and availability.

    Aug 10, 2017

  • Proposed and Final FDA Rules What’s Left in 2017

    RAPS |  The US Food and Drug Administration (FDA) is planning to release seven proposed rules and six final rules to close out 2017, according to an updated list of Department of Health and Human Services rulemakings.

    Aug 9, 2017

  • It’s About Time: Stop the IRB as a Regulatory Compliance Committee

    Clinical Informatics News | It's About Time | Scott Lipkin, Managing Director at FTI Consulting, thinks it's high time that IRBs stop acting a regulatory compliance committees. "Few, if any IRBs have the expertise, time, or administrative resources to properly investigate and provide a determination of serious or continuing noncompliance, craft a management plan, and perhaps monitor corrective actions," he says. 

    Aug 7, 2017

  • Best Doctors acquisition will push Teladoc into chronic care hospital follow-ups

    MobiHealthNews |  Teladoc CEO Jason Gorevic certainly had a lot to talk about on yesterday's Q2 earnings call. Referencing the recent legislation in Texas and the company's acquisition of Best Doctors, Gorevic called Q2 2017 "the most exciting quarter in the company's history".

    Aug 7, 2017

  • TrialScope Launches Disclosure Tool

    Clinical Informatics News Brief | TrialScope yesterday launched Core Disclosure, enabling teams to approve disclosure content once and then reuse the disclosure data around the globe. The product is intended to promote a new level of data efficiency accuracy and alignment.

    Aug 4, 2017

  • Evidence for Health Decision Making — Beyond Randomized Controlled Trials

    New England Journal of Medicine |  Tom Frieden again weighs in with evidence for health decision making beyond clinical trials. "Although randomized, controlled trials have long been presumed to be the ideal source of data on the effects of treatment, other methods of obtaining evidence for decisions action are receiving increased interest," he writes.

    Aug 4, 2017

  • Why The Gold Standard Of Medical Research Is No Longer Enough

    STAT |  Tom Frieden, former director of the Centers for Disease Control and Prevention, explains why he believes it's time to look beyond randomized controlled trials and use other study types to understand the "dark matter" of clinical medicine.

    Aug 3, 2017

  • WIRB-Copernicus Group, inVentiv Health, National Institutes of Health, And More: News From July 2017

    Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from WIRB-Copernicus Group, inVentiv Health, National Institutes of Health, and more.

    Aug 2, 2017

  • ThoughtSphere Builds A Data Lake For Clinical Trials

    Clinical Informatics News | Our old ways of connecting to data are dead, Sudeep Pattnaik told me. ThoughtSphere is a data lake, an architecture meant to collect vast pools of data from varied sources, and it’s focusing on clinical research data.

    Aug 1, 2017

  • Vaccines are part of the solution to the crisis of antibiotic resistance

    STAT |  Wiser use of antibiotics is one solution to the growing crisis of antibiotic resistance. Wider use of vaccines is another.

    Aug 1, 2017

  • Governance In Pharmaceutical Projects

    Clinical Informatics News Contributed Commentary | The scientific, technical, and regulatory challenges related to drug development have created complexities. Such complexities include pharma project challenges and the function and objectives of a successful Enterprise Project Management Office.

    Jul 28, 2017

  • Big And Small Companies See Clinical Trial Transparency Differently Says TrialScope CSO

    Clinical Informatics News | Clinical trial disclosure is now mandated by both FDA and EMA, but TrialScope’s Thomas Wicks believes there much more to clinical trial transparency than simply the letter of the law. And he sees a big difference in how large and small companies are dealing with it.

    Jul 26, 2017